BACKGROUND. Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are highly comorbid and exhibit strong correlations with one another. We aimed to investigate mechanisms of underlying relationships between PTSD and 3 kinds of depressive phenotypes, namely, MDD, depressed affect (DAF), and depression (DEP, including both MDD and the broad definition of depression). METHODS. Genetic correlations between PTSD and the depressive phenotypes were tested using linkage disequilibrium score regression. Polygenic overlap analysis was used to estimate shared and trait-specific causal variants across a pair of traits. Causal relationships between PTSD and the depressive phenotypes were investigated using Mendelian randomization. Shared genomic loci between PTSD and MDD were identified using cross-trait meta-analysis. RESULTS. Genetic correlations of PTSD with the depressive phenotypes were in the range of 0.71–0.80. The estimated numbers of causal variants were 14,565, 12,965, 10,565, and 4,986 for MDD, DEP, DAF, and PTSD, respectively. In each case, causal variants contributing to PTSD were completely or largely covered by causal variants defining each of the depressive phenotypes. Mendelian randomization analysis indicated that the genetically determined depressive phenotypes confer a causal effect on PTSD (b = 0.21–0.31). Notably, genetically determined PTSD confers a causal effect on DEP (b = 0.14) and DAF (b = 0.15), but not MDD. Cross-trait meta-analysis of MDD and PTSD identified 47 genomic loci, including 29 loci shared between PTSD and MDD. CONCLUSION. Evidence from shared genetics suggests that PTSD is a subtype of MDD. This study provides support to the efforts in reducing diagnostic heterogeneity in psychiatric nosology. FUNDING. The National Key Research and Development Program of China and the National Natural Science Foundation of China.
23 January 2018 in IEEE Journal of Biomedical and Health Informatics
The fractional amplitude of low-frequency fluctuations (fALFF) has been widely used as potential clinical biomarkers for resting-state functional magnetic resonance imaging based schizophrenia diagnosis. However, previous studies usually measure the fALFF with specific bands from 0.01-0.08 Hz, which cannot fully delineate the complex variations of spontaneous fluctuations in the resting-state brain. As we konow, fALFF data is intrinsically constrained by the brain structure, but most of the traditional methods have not consider it in feature selection. For addressing these problems, we propose a model to classify schizophrenia in multi-frequency bands with tree-guided group sparse learning. In detail, we first acquire the fALFF data in multi-frequency bands (i.e., slow-5:0.01-0.027 Hz, slow-4:0.027-0.073 Hz, slow-3:0.073-0.198 Hz and slow-2:0.198-0.25 Hz). Then, we divide the whole brain into different candidate patches, and select those significant patches related to schizophrenia using random forest-based importancescore. Moreover, we use tree-structured sparse learning method for feature selection with above patches spatial constraint. Finally, considering biomarkers from multi-frequency bands can reflect complementary information among multiple frequency bands, we adopt the multi-kernel learning (MKL) method to combine features of multi-frequency bands for classification. Our experimental results show that these biomarkers from multi-frequency bands can achieve a classification accuracy of 91.1% on 17 schizophrenia patients and 17 healthy controls, further demonstrating the multi-frequency bands analysis can better account for classification of schizophrenia.
Brain functional connectivity network (BFCN) analysis has been widely used in the diagnosis of mental disorders, such as schizophrenia. In BFCN methods, brain network construction is one of the core tasks due to its great influence on the diagnosis result. Most of the existing BFCN construction methods only consider the first-order relationship existing in each pair of brain regions and ignore the useful high-order information, including multi-region correlation in the whole brain. Some early schizophrenia patients have subtle changes in brain function networks, which cannot be detected in conventional BFCN construction methods. It is well-known that the high-order method is usually more sensitive to the subtle changes in signal than the low-order method. To exploit high-order information among brain regions, we define the triplet correlation among three brain regions, and derive the second-order brain network based on the connectivity difference and ordinal information in each triplet. For making full use of the complementary information in different brain networks, we proposed a hybrid approach to fuse the first- and second-order brain networks. The proposed method is applied to identify the biomarkers of schizophrenia. The experimental results on six schizophrenia datasets (totally including 439 patients and 426 controls) show that the proposed method outperforms the existing brain network methods in the diagnosis of schizophrenia.
27 June 2022 in IEEE Transactions on Medical Imaging
In recent years, numerous studies have adopted rs-fMRI to construct dynamic functional connectivity networks (DFCNs) and applied them to the diagnosis of brain diseases, such as epilepsy and schizophrenia. Compared with the static brain networks, the DFCNs have a natural advantage in reflecting the process of brain activity due to the time information contained in it. However, most of the current methods for constructing DFCNs fail to aggregate the brain topology structure and temporal variation of the functional architecture associated with brain regions, and often ignore the inherent multi-dimensional feature representation of DFCNs for classification. In order to address these issues, we propose a novel DFCNs construction and representation method and apply it to brain disease diagnosis. Specifically, we fuse the blood oxygen level dependent (BOLD) signal and interactions between brain regions to distinguish the brain topology within each time domain and across different time domains, by embedding block structure in the adjacency matrix. After that, a sparse tensor decomposition method with sparse local structure preserving regularization is developed to extract DFCNs features from a multi-dimensional perspective. Finally, the kernel discriminant analysis is employed to provide the decision result. We validate the proposed method on epilepsy and schizophrenia identification tasks, respectively. The experimental results show that the proposed method outperforms several state-of-the-art methods in the diagnosis of brain diseases.
Our study aimed to explore the abnormal spontaneous brain activity by regional homogeneity (ReHo) and its association with cognitive function to understand the neuropathology of major depressive disorder (MDD). ReHo was used to investigate brain activities of 60 patients with first-episode drug-naive MDD and 60 healthy controls (HCs). Partial correlation analysis was conducted on altered ReHo values and the severity of symptoms and cognitive deficits. Moreover, support vector machine analysis was used to evaluate the accuracy of abnormal ReHo values in distinguishing patients with MDD from HCs. Compared with HCs, patients with MDD showed significantly increased ReHo values in the right cerebellum crus2 and right thalamus and decreased ReHo values in the right angular gyrus (AG) and right precuneus (PCUN). The ReHo values in right cerebellum crus2 and right AG were positively associated with working memory and visual learning, respectively. Furthermore, the combination of ReHo values in the right cerebellum crus2 and right PCUN discriminated the patients with MDD from HCs with specificity, sensitivity, and accuracy of 0.9688, 0.6250, and 0.90, respectively. The design of repeated cross-sectional surveys does not allow analyses of within individual changes. Our study revealed that the pathophysiology mechanism of cognitive deficits in MDD may be related to abnormal spontaneous brain activity. Moreover, the combination of ReHo values in the right cerebellum crus2 and right PCUN can be used to discriminate patients with MDD from HCs effectively.
Background: Patients with treatment-resistant schizophrenia (TRS) and non-treatment-resistant schizophrenia (NTRS) respond to antipsychotic drugs differently. Previous studies demonstrated that patients with TRS or NTRS exhibited abnormal neural activity in different brain regions. Accordingly, in the present study, we tested the hypothesis that a regional homogeneity (ReHo) approach could be used to distinguish between patients with TRS and NTRS. Methods: A total of 17 patients with TRS, 17 patients with NTRS, and 29 healthy controls (HCs) matched in sex, age, and education levels were recruited to undergo resting-state functional magnetic resonance imaging (RS-fMRI). ReHo was used to process the data. ANCOVA followed by post-hoc t-tests, receiver operating characteristic curves (ROC), and correlation analyses were applied for the data analysis. Results: ANCOVA analysis revealed widespread differences in ReHo among the three groups in the occipital, frontal, temporal, and parietal lobes. ROC results indicated that the optimal sensitivity and specificity of the ReHo values in the left postcentral gyrus, left inferior frontal gyrus/triangular part, and right fusiform could differentiate TRS from NTRS, TRS from HCs, and NTRS from HCs were 94.12 and 82.35%, 100 and 86.21%, and 82.35 and 93.10%, respectively. No correlation was found between abnormal ReHo and clinical symptoms in patients with TRS or NTRS. Conclusions: TRS and NTRS shared most brain regions with abnormal neural activity. Abnormal ReHo values in certain brain regions might be applied to differentiate TRS from NTRS, TRS from HC, and NTRS from HC with high sensitivity and specificity.